Hepatitis C Virus (HCV) is globally the largest viral cause of mortality. Directly Acting Antiviral (DAA) therapy achieves >90% sustained virological response in HCV patients. We used multiparametric MRI to assess changes in hepatic angio-architecture after patients had DAA therapy. The time window between pre- and post-treatment scans was of 3-6 months. We observed changes in hepatic microstructure indicated by a reduction in liver T1 (35±4ms), T2 (2.5±0.8ms) and T2* (3.0±0.7ms) which we suggest are linked to reduced pro-inflammatory milieu, including interstitial oedema, within the liver. No changes were observed in hepatic/splanchnic blood flow or perfusion.